DK0457163T3 - Anvendelse af oxalyl-aminosyrederivater som lægemidler til inhibering af prolyl-hydroxylase - Google Patents

Anvendelse af oxalyl-aminosyrederivater som lægemidler til inhibering af prolyl-hydroxylase

Info

Publication number
DK0457163T3
DK0457163T3 DK91107424.3T DK91107424T DK0457163T3 DK 0457163 T3 DK0457163 T3 DK 0457163T3 DK 91107424 T DK91107424 T DK 91107424T DK 0457163 T3 DK0457163 T3 DK 0457163T3
Authority
DK
Denmark
Prior art keywords
acid derivatives
drugs
inhibition
amino acid
alkyl
Prior art date
Application number
DK91107424.3T
Other languages
English (en)
Inventor
Ekkehard Dr Baader
Harald Dr Burghard
Volkmar Dr Guenzler-Pukall
Original Assignee
Hoechst Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoechst Ag filed Critical Hoechst Ag
Application granted granted Critical
Publication of DK0457163T3 publication Critical patent/DK0457163T3/da

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/185Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19Carboxylic acids, e.g. valproic acid
    • A61K31/195Carboxylic acids, e.g. valproic acid having an amino group
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C323/00Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups
    • C07C323/50Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and carboxyl groups bound to the same carbon skeleton
    • C07C323/51Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and carboxyl groups bound to the same carbon skeleton having the sulfur atoms of the thio groups bound to acyclic carbon atoms of the carbon skeleton
    • C07C323/57Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and carboxyl groups bound to the same carbon skeleton having the sulfur atoms of the thio groups bound to acyclic carbon atoms of the carbon skeleton the carbon skeleton being further substituted by nitrogen atoms, not being part of nitro or nitroso groups
    • C07C323/58Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and carboxyl groups bound to the same carbon skeleton having the sulfur atoms of the thio groups bound to acyclic carbon atoms of the carbon skeleton the carbon skeleton being further substituted by nitrogen atoms, not being part of nitro or nitroso groups with amino groups bound to the carbon skeleton
    • C07C323/59Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and carboxyl groups bound to the same carbon skeleton having the sulfur atoms of the thio groups bound to acyclic carbon atoms of the carbon skeleton the carbon skeleton being further substituted by nitrogen atoms, not being part of nitro or nitroso groups with amino groups bound to the carbon skeleton with acylated amino groups bound to the carbon skeleton
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/16Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • A61P37/02Immunomodulators
    • A61P37/06Immunosuppressants, e.g. drugs for graft rejection
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/10Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C233/00Carboxylic acid amides
    • C07C233/01Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms
    • C07C233/56Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms having carbon atoms of carboxamide groups bound to carbon atoms of carboxyl groups, e.g. oxamides
DK91107424.3T 1990-05-12 1991-05-07 Anvendelse af oxalyl-aminosyrederivater som lægemidler til inhibering af prolyl-hydroxylase DK0457163T3 (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE4015255A DE4015255A1 (de) 1990-05-12 1990-05-12 Oxalyl-aminosaeurederivate, verfahren zu ihrer herstellung und ihrer verwendung als arzneimittel zur inhibierung der prolyl-hydroxylase

Publications (1)

Publication Number Publication Date
DK0457163T3 true DK0457163T3 (da) 1994-10-17

Family

ID=6406245

Family Applications (1)

Application Number Title Priority Date Filing Date
DK91107424.3T DK0457163T3 (da) 1990-05-12 1991-05-07 Anvendelse af oxalyl-aminosyrederivater som lægemidler til inhibering af prolyl-hydroxylase

Country Status (28)

Country Link
US (1) US5204338A (da)
EP (1) EP0457163B1 (da)
JP (1) JP2504874B2 (da)
KR (1) KR910019612A (da)
CN (1) CN1032253C (da)
AT (1) ATE108177T1 (da)
AU (1) AU641760B2 (da)
BR (1) BR9101927A (da)
CA (1) CA2042282A1 (da)
CZ (1) CZ279939B6 (da)
DE (2) DE4015255A1 (da)
DK (1) DK0457163T3 (da)
EG (1) EG19762A (da)
ES (1) ES2057655T3 (da)
HR (1) HRP940695B1 (da)
HU (1) HU217974B (da)
IE (1) IE65298B1 (da)
IL (1) IL98109A (da)
LT (1) LT3953B (da)
LV (1) LV10387B (da)
MA (1) MA22152A1 (da)
MX (1) MX25723A (da)
MY (1) MY108608A (da)
NZ (1) NZ238112A (da)
PT (1) PT97642B (da)
RU (1) RU2025123C1 (da)
TW (1) TW225988B (da)
ZA (1) ZA913538B (da)

Families Citing this family (38)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5192773A (en) * 1990-07-02 1993-03-09 Vertex Pharmaceuticals, Inc. Immunosuppressive compounds
US5620971A (en) * 1991-05-09 1997-04-15 Vertex Pharmaceuticals Incorporated Biologically active acylated amino acid derivatives
AU1995792A (en) * 1991-05-09 1992-12-21 Vertex Pharmaceuticals Incorporated Novel immunosuppressive compounds
US5723459A (en) * 1991-05-09 1998-03-03 Vertex Pharmaceuticals Incorporated Biologically active acylated amino acid derivatives
DK0650961T3 (da) 1993-11-02 1997-09-15 Hoechst Ag Substituerede heterocykliske carboxylsyreamider, deres fremstilling og deres anvendelse som lægemidler.
ATE149485T1 (de) * 1993-11-02 1997-03-15 Hoechst Ag Substituierte heterocyclische carbonsäureamidester, ihre herstellung und ihre verwendung als arzneimittel
NZ270267A (en) * 1993-12-30 1997-03-24 Hoechst Ag 3-hydroxypyridin-2yl (and -quinolin-2-yl) carboxamide derivatives and pharmaceutical compositions
US5543423A (en) * 1994-11-16 1996-08-06 Vertex Pharmaceuticals, Incorporated Amino acid derivatives with improved multi-drug resistance activity
US5789426A (en) * 1995-01-20 1998-08-04 Cornell Research Foundation, Inc. Method for the treatment of fibroproliferative disorders by application of inhibitors of protein hydroxylation
US6046219A (en) * 1995-01-20 2000-04-04 Cornell Research Foundation, Inc. Method for the treatment of conditions mediated by collagen formation together with cell proliferation by application of inhibitors of protein hydroxylation
US5859031A (en) 1995-06-07 1999-01-12 Gpi Nil Holdings, Inc. Small molecule inhibitors of rotamase enzyme activity
US7056935B2 (en) 1995-06-07 2006-06-06 Gpi Nil Holdings, Inc. Rotamase enzyme activity inhibitors
IL135495A (en) * 1995-09-28 2002-12-01 Hoechst Ag Intermediate compounds for the preparation of quinoline-converted amines - 2 - carboxylic acid
US5801197A (en) * 1995-10-31 1998-09-01 Gpi Nil Holdings, Inc. Rotamase enzyme activity inhibitors
US5717092A (en) * 1996-03-29 1998-02-10 Vertex Pharmaceuticals Inc. Compounds with improved multi-drug resistance activity
US6218424B1 (en) 1996-09-25 2001-04-17 Gpi Nil Holdings, Inc. Heterocyclic ketone and thioester compounds and uses
US5801187A (en) 1996-09-25 1998-09-01 Gpi-Nil Holdings, Inc. Heterocyclic esters and amides
US5786378A (en) * 1996-09-25 1998-07-28 Gpi Nil Holdings, Inc. Heterocyclic thioesters
DE19650215A1 (de) * 1996-12-04 1998-06-10 Hoechst Ag 3-Hydroxypyridin-2-carbonsäureamidester, ihre Herstellung und ihre Verwendung als Arzneimittel
US20010049381A1 (en) 1997-06-04 2001-12-06 Gpl Nil Holdings, Inc., Pyrrolidine derivative hair growth compositions and uses
US5945441A (en) * 1997-06-04 1999-08-31 Gpi Nil Holdings, Inc. Pyrrolidine carboxylate hair revitalizing agents
US6271244B1 (en) 1998-06-03 2001-08-07 Gpi Nil Holdings, Inc. N-linked urea or carbamate of heterocyclic thioester hair growth compositions and uses
US6274602B1 (en) 1998-06-03 2001-08-14 Gpi Nil Holdings, Inc. Heterocyclic thioester and ketone hair growth compositions and uses
US6187784B1 (en) 1998-06-03 2001-02-13 Gpi Nil Holdings, Inc. Pipecolic acid derivative hair growth compositions and uses
US6187796B1 (en) 1998-06-03 2001-02-13 Gpi Nil Holdings, Inc. Sulfone hair growth compositions and uses
DE19746287A1 (de) * 1997-10-20 1999-04-22 Hoechst Marion Roussel De Gmbh Substituierte Isochinolin-2-Carbonsäureamide, ihre Herstellung und ihre Verwendung als Arzneimittel
AU770459B2 (en) 1998-06-03 2004-02-19 Gpi Nil Holdings, Inc. Heterocyclic ester and amide hair growth compositions and uses
US6331537B1 (en) 1998-06-03 2001-12-18 Gpi Nil Holdings, Inc. Carboxylic acids and carboxylic acid isosteres of N-heterocyclic compounds
US6429215B1 (en) 1998-06-03 2002-08-06 Gpi Nil Holdings, Inc. N-oxide of heterocyclic ester, amide, thioester, or ketone hair growth compositions and uses
US6172087B1 (en) 1998-06-03 2001-01-09 Gpi Nil Holding, Inc. N-oxide of heterocyclic ester, amide, thioester, or ketone hair growth compositions and uses
US6333340B1 (en) 1998-08-14 2001-12-25 Gpi Nil Holdings, Inc. Small molecule sulfonamides for vision and memory disorders
US6335348B1 (en) 1998-08-14 2002-01-01 Gpi Nil Holdings, Inc. Nitrogen-containing linear and azepinyl/ compositions and uses for vision and memory disorders
US7338976B1 (en) 1998-08-14 2008-03-04 Gpi Nil Holdings, Inc. Heterocyclic esters or amides for vision and memory disorders
US6384056B1 (en) 1998-08-14 2002-05-07 Gpi Nil Holdings, Inc. Heterocyclic thioesters or ketones for vision and memory disorders
US6506788B1 (en) 1998-08-14 2003-01-14 Gpi Nil Holdings, Inc. N-linked urea or carbamate of heterocyclic thioesters for vision and memory disorders
US6462072B1 (en) 1998-09-21 2002-10-08 Gpi Nil Holdings, Inc. Cyclic ester or amide derivatives
WO2003053997A2 (en) * 2001-12-06 2003-07-03 Fibrogen, Inc. Methods of increasing endogenous erythropoietin (epo)
TW200718417A (en) * 2005-06-15 2007-05-16 Nippon Zoki Pharmaceutical Co Agent for fibrous diseases comprising oxaluric acid derivatives

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE1645987A1 (de) * 1966-08-08 1971-01-21 Ajinomoto Kk Oxalzolderivate und Verfahren zu deren Herstellung
FR1533817A (fr) * 1966-08-08 1968-07-19 Ajinomoto Kk Dérivés d'oxazole et leur procédé de préparation
US3646061A (en) * 1968-06-10 1972-02-29 Ajinomoto Kk Method of preparing n-alkoxalyl and n-formyl derivatives of alpha-amino acid esters

Also Published As

Publication number Publication date
HU157291D0 (en) 1991-11-28
ATE108177T1 (de) 1994-07-15
MY108608A (en) 1996-10-31
IL98109A (en) 1995-07-31
IL98109A0 (en) 1992-06-21
MX25723A (es) 1993-04-01
LTIP1460A (en) 1995-05-25
HRP940695B1 (en) 1999-04-30
MA22152A1 (fr) 1991-12-31
PT97642B (pt) 1998-08-31
LV10387A (lv) 1995-02-20
DE59102102D1 (de) 1994-08-11
EG19762A (en) 1996-01-31
KR910019612A (ko) 1991-12-19
AU7622191A (en) 1991-11-14
RU2025123C1 (ru) 1994-12-30
CZ279939B6 (cs) 1995-09-13
PT97642A (pt) 1992-02-28
EP0457163B1 (de) 1994-07-06
CA2042282A1 (en) 1991-11-13
ZA913538B (en) 1992-02-26
HU217974B (hu) 2000-05-28
AU641760B2 (en) 1993-09-30
US5204338A (en) 1993-04-20
ES2057655T3 (es) 1994-10-16
LV10387B (en) 1996-02-20
JP2504874B2 (ja) 1996-06-05
TW225988B (da) 1994-07-01
IE911608A1 (en) 1991-11-20
HUT57581A (en) 1991-12-30
CN1032253C (zh) 1996-07-10
LT3953B (en) 1996-05-27
IE65298B1 (en) 1995-10-18
JPH04226913A (ja) 1992-08-17
EP0457163A1 (de) 1991-11-21
CN1056683A (zh) 1991-12-04
HRP940695A2 (en) 1997-02-28
DE4015255A1 (de) 1991-11-14
BR9101927A (pt) 1991-12-17
NZ238112A (en) 1993-12-23

Similar Documents

Publication Publication Date Title
DK0457163T3 (da) Anvendelse af oxalyl-aminosyrederivater som lægemidler til inhibering af prolyl-hydroxylase
DE69615808D1 (de) Camphothecinderivate
TR200100438T2 (tr) Hepatit C inhibitörü peptitler
ES2114645T3 (es) Utilizacion de un fosfato de alfa-tocoferol, o de uno de sus derivados para la preparacion de una composicion cosmetica, dermatologica o farmaceutica, de actividad anti-radicalar; composicion asi obtenida.
DE69604714D1 (de) Stilbenderivate und diese enthaltende pharmazeutische Zusammensetzungen
ATE288739T1 (de) Solubilisierung von 1,3,5-triazinderivaten mittels estern von n-acylaminosäuren
ES2080922T3 (es) Derivados de la n-sulfonil-indolina, su preparacion, y las composiciones farmaceuticas que los contienen.
NO931888L (no) Cyclopeptider og anvendelser derav p} slimhinner
ES2108066T3 (es) Nuevas ftalazinas que en posicion 1 contienen una agrupacion eter, y procedimiento para su preparacion.
FI920435A (fi) N-(aryloxyalkyl) heteroaryl-8 -azabicyclo/3.2.1./oktaner, mellanprodukter och deras framstaellnings -foerfarande och deras anvaendning som laekemedel.
ES2037613A1 (es) Procedimiento de obtencion de nuevos derivados dipeptidicos.
YU73202A (sh) Novi proces za sintezu n-/(s)-1-karboksibutil/-(s)- alaninskog estra i primena u sintezi perindoprila
TW333533B (en) Novel indane-2-mercaptoacetylamide disulfide derivatives useful as inhibitors of enkephalinase
ATE109480T1 (de) N-(5,6,7,8-tetrahydropyrido(2,3-d)pyrimidin-6-y - alkanoyl)-glutaminsäure-derivate.